With the discovery of hpGRF and hCRF pituitary function can be assessed by the use of four physiologic releasing hormones. After a rest of two hours to reach basal cortisol levels, healthy young male volunteers received a bolus of the following releasing hormones: 1) GRF (100 119) + CRF (50 09) + TRH ( 2 W pg) + LIWI (1Wug) 2) GRF + TRH 3) CRF + TRH 4) LHRH + TRH 5) each releasing hormone alone (n=5 in each group). During the following two hours, GH, ACTH, cortisol, TSH, LH, FSH and prolactin were measured every fifteen minutes. The combination of the four releasing hormones resulted in a rapid rise of all measured hormones with the following peak values:
sponse to TRH was shown to be entirely due to additional GRF administration, CRF in combination with TRH had no additional effect on TSH release. For all other measured hormones we found no significant differences between application of a single releasing hormone and the combinations studied (analysis of variance). We conclude that: 1) The combined injection of four releasing hormones provides a valuable test for anterior pituitary function. As there are practically no side effects, application in children is favored. The diagnosis was not reached in one neonate who suffered from Glucose-6-Phosphatase deficiency and who presented initially without lactic acidosis. Once he developed lactic acidosis he fitted perfectly into the algorithm. T h e prevalence of 52 congenital minor anomalies /MCAs/ was determined i n 111 children with insulin dependent diabetes mellitus /IDDEl/, and in 111 healthy matched control subjects. T h e average MCA per person was 1.60 i n diabetic children and 0,86 i n the controls /p<o,ool/ T h e difference wes exclusively due to the significantly higher proportion of subjects with 3 o r more MCAs in the diabetic group /27,0 versus 9,s per cent, p<o,ool/.
Malformation type minor anomalies /"mild malformetions"/ minor dysplasias, deformations, and phenogenetic variants almost equally contributed to the higher prevalence of MCAs i n the patients. N o specific MCA characteristic of IDDM w a s found.
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RING CHROMOSOME WITH NO MALFORMATION BUT EXTREME SOMATIC RETARDATION:"RING SYNDROME"? A REVIEW OF 206 CASE REPORTS G. Kosztolinyi, Dept.Ped.Med.Univ.PQcs,Hungary Many patients with ring autosomes who had no organic malformation and no or only a few nonspecific dysmorphic stigmata, showed extreme somatic retardation (eSR) the cause of which is not fully understood. Motivated by 4 own patients, the author analysed 206 reports out of about 300 cases with ring autosome known in the literature in order to shed some light upon this phenotype ("ring syndrome"). Cases with no detectable loss of chromosomal material were included only. eSR was defined as height > 3 SD below the mean. Statistics were done by x2
test. -Out of 206-cases, 114 had no organic malformation, no specific deletion syndrome and no or only a few nonspecific dysmorphic signs. Of these, 40 cases (one fifth of the total), had eSR, while 31 had normal height (NH). The ratio of eSR to NH was greater with high significance among 81 patients with ring of larger chromosomes (No 1-15) than among 33 patients with smaller ones (No 16-22), namely 37:9 and 3:22, respectively, indicating that the greater the chromosome involved, the higher is the probability of severe growth failure. -Cases were analysed according to the frequency of secundary chromosomal aneuploidy (sCA), a consequence of specific ring behaviour during mitosis. Out of 53 cases having sCA in 0-5 X of mitoses ("stable ring"), 13 (24 X) had eSR and 20 (38 7). had NH, while of 84 cases having sCA in more than 5 % of mitoses ("labile ring"), 38 (45 Z) had eSR and only 1 1 (13 X) had NH (for eSR p <0.001). It is suggested that -rather than a loss of specific material prior to ring formation -the specific ring behaviour per se is causing "ring syndrome" in one fifth of cases with ring chromosome. Both vitamin E and zinc deficiency continue to be observed in the very low birth-weight infants despite the use of dietary supplements.
ITAMIN E MALABSORPTION IN GROWING PRETERM INFANTS WITH
The interrelationship between vitamin E and zinc nutrition was sequentially evaluated in 58 formula fed growing preterm neonates (birth weight: X t SD, 1043t121g, gestational age: X + SD, 2920.4 wks).
Enteral feeds contained zinc (300mg/100ml) and supplemental vitamin E (to achieve sufficient serum E level of I-2mgIdl). Three groups of infants were identified on data analyses. Group 1 (27158) had sufficient serum zinc (>70mcgldl) and vitamin E (1-3mg/dl) levels on mean E supplement of 55210 SD 1.U.Iday. Group I1 (15158) were hypozincemic (<70mcg/dl) but had no other evidence of zinc deficiency. These infants had sufficient serum E levels on a mean E supplement of 71220 SD I.U./day. Group 111 (16158) were hypozincemic (<70mg/dl) and had edema and hypoproteinemia. Their mean serum vitamin E level was only 0.8mgldlt0.4 SD in spite of their having received significantly (p< 0.001) higher supplement of vitamin E (162t25 SD I.U./day) than Group I and I1 infants. Correction of hypozincemia with therapeutic doses of oral zinc was associated with a prompt and striking improvement of serum vitamin E absorption. During the 4 week period of zinc therapy. vitamin E supplements had to be significantly reduced (0-25 I.U./day) to maintain physiologic E levels. These data demonstrate significant but reversible vitamin E malabsorption in preterm neonates with symptomatic zinc deficiency. Concurrent monitoring of both vitamin E and zinc serum levels is recommended.
